Redwood Scientific Technologies, Inc.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Redwood Scientific Technologies, Inc. develops and markets homeopathic products which feature oral strip delivery technology. The company was founded by Jason Cardiff on December 4, 1986 and is headquartered in Albany, NY.

NEW YORK , May 23, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) is excited to announce the finalization of the first five flavors of its innovative TBX VAPE FREE strips. This product marks a significant milestone as the company works to pioneer the vape cessation category.

Redwood Scientific Technologies Inc. Announces Finalization of TBX VAPE FREE Product Flavors

NEW YORK , April 18, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities. The New York-based firm will only focus on enhancing and expanding its nicotine replacement therapy (NRT) products, specifically TBX-FREE™ and TBX VAPE-FREE™.

Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities

NEW YORK , March 14, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) is excited to announce significant milestones achieved in the year ending 2023 and its strategic plans moving forward. The company has conveyed to the Board its confidence in its role as a developer of innovative pharmaceutical products, positioning itself for sustained success over the next 36 months.

Company Initiates Plans to Build Oral Thin Film Manufacturing in the USA for Its Stop Smoking and Stop Vaping Products

Company Has Engaged George Mason University to Conduct Efficacy Study on its New Product NEW YORK , Feb. 6, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI), ("Redwood" or "the Company"), a pioneering pharmaceutical company headquartered in New York, announced today that it has entered into an agreement with Jeeva Clinical Trials to launch a clinical effectiveness study of its TBX-Free oral strips products for smoking and e-cigarette cessation. The company has engaged top U.S. institution, George Mason University, to conduct the efficacy study on this new product.

Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation

NEW YORK , Sept. 18, 2023 /PRNewswire/ -- Redwood Scientific Technologies is delighted to announce the successful filing of its S1 registration statement with the Securities and Exchange Commission (SEC).

Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress

NEW YORK , Aug. 15, 2023 /PRNewswire/ -- Redwood Scientific Technologies Inc. wishes to correct a previous press release issued on July 19th.

Redwood Scientific Technologies Inc. (RSCI. OTC. PK) Issues Correction Regarding Agreement with Silk Road Ent.

News for Redwood Scientific Technologies, Inc. Stock (RSCI)